Access to the CNS: Biomarker Strategies for Dopaminergic Treatments
Pharmaceutical Research - United States
doi 10.1007/s11095-017-2333-x
Full Text
Open PDFAbstract
Available in full text
Date
February 15, 2018
Authors
Publisher
Springer Science and Business Media LLC